6 withdrawn. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Withdrawn 6 |
Follow Surgery: new trials by email Literature Review of Surgery trials Research Report on Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Transverse Abdominus Plane Block Study Ropivacaine, Dexmedetomidine, Dexamethasone sodium phosphate, Normal saline, Liposomal bupivacaine - Colorectal Disorders, Surgery | Phase 2 | Withdrawn | University of Colorado, Denver | 2022-04-19 | 2023-03-06 | |
| Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery Tranexamic acid, Placebo - Pituitary Tumor, Blood Loss | Phase 2 | Withdrawn | University of North Carolina, Chapel Hill | 2022-03-01 | 2022-04-05 | |
| Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC Cetuximab - Lung Cancer, Surgery | Phase 2 | Withdrawn | The Netherlands Cancer Institute | 2022-01-01 | 2023-10-19 | |
| Surgery of Melanoma Metastases After Systemic Therapy Surgical metastasectomy, Immunotherapy - Melanoma, Melanoma Stage IV | Phase 2 | Withdrawn | Vastra Gotaland Region | 2021-03-11 | 2024-01-26 | |
| Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition Galacto-Oligosaccharide, Maltodextrin (Placebo) - Anxiety, Pain | Phase 2 | Withdrawn | Jeff Taekman, M.D. | 2017-06-09 | 2018-01-31 | |
| Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer PG2, Placebo - Cancer, Surgery | Phase 2 | Withdrawn | PhytoHealth Corporation | 2014-02-01 | 2025-06-04 |
Anxiety Disorders (1) · Fatigue (1) · Hemorrhage (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasms (1) · Neoplastic Cells, Circulating (1) · Pain (1) · Pituitary Neoplasms (1)
Pathological Conditions, Signs and Symptoms (4) · Neoplasms (3) · Neoplasms by Site (3) · Pathologic Processes (2) · Signs and Symptoms (2) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Hypothalamic Diseases (1) · Hypothalamic Neoplasms (1) · Lung Diseases (1) · Mental Disorders (1)
4'-galactooligosaccharide (1) · Cetuximab (1) · Dexmedetomidine (1) · Immunotherapy (1) · Ropivacaine (1) · Saline Solution (1) · Tranexamic Acid (1) · dexamethasone 21-phosphate (1) · maltodextrin (1)
Jeff Taekman, M.D. (1) · PhytoHealth Corporation (1) · The Netherlands Cancer Institute (1) · University of Colorado, Denver (1) · University of North Carolina, Chapel Hill (1) · Vastra Gotaland Region (1)
Netherlands (1) · Sweden (1) · Taiwan (1) · United States (1)
Brandon C Chapman (1) · Brent Senior, MD (1) · Egbert Smit, prof (1) · Jeffrey M Taekman, M.D. (1) · Jin-Ming Wu, M.D. (1) · Marjolein van Egmond, prof (1)